EOLS FY 2022 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena

EOLSEvolus, Inc.

$353M

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$149M+49.1% YoY

Gross Profit

$90M60.4% margin

Operating Income

-$65M-44.0% margin

Net Income

-$74M-50.1% margin

EPS (Diluted)

$-1.33

Cash Flow

Operating Cash Flow

-$85M

Free Cash Flow

-$88M

Stock-Based Comp.

$11M

Balance Sheet

Total Assets

$178M

Total Liabilities

$159M

Stockholders' Equity

$18M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$149M	$100M	+49.1%
Gross Profit	$90M	$56M	+59.9%
Operating Income	-$65M	-$44M	-47.1%
Net Income	-$74M	-$47M	-59.0%